Aim: To assess the role of allogenic bone marrow (ABM) transplantation in chronic myeloid leukemia (CML).
Material And Methods: 44 ABM transplantations were performed in 37 CML patients in the chronic phase and 7 patients in acceleration or blast crisis.
Results: A complete molecular remission was achieved in 26 (59%) patients: 67.